These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6195262)

  • 1. Localization of the phosphocholine-binding sites on C-reactive protein by immunoelectron microscopy.
    Roux KH; Kilpatrick JM; Volanakis JE; Kearney JF
    J Immunol; 1983 Nov; 131(5):2411-5. PubMed ID: 6195262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of human C-reactive protein (CRP) to plasma fibronectin occurs via the phosphorylcholine-binding site.
    Tseng J; Mortensen RF
    Mol Immunol; 1988 Aug; 25(8):679-86. PubMed ID: 2460754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies to the calcium-binding region peptide of human C-reactive protein alter its conformation.
    Swanson SJ; Mullenix MC; Mortensen RF
    J Immunol; 1991 Oct; 147(7):2248-52. PubMed ID: 1717553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies to human C-reactive protein (CRP) that recognize epitopes in functional regions.
    Tseng JM; Diiorio L; Mortensen RF
    Hybridoma; 1988 Apr; 7(2):185-91. PubMed ID: 2453452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of human serum amyloid P-component to phosphocholine.
    Christner RB; Mortensen RF
    Arch Biochem Biophys; 1994 Nov; 314(2):337-43. PubMed ID: 7979374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactivity between C-reactive protein and idiotypic determinants on A phosphocholine-binding murine myeloma protein.
    Volanakis JE; Kearney JF
    J Exp Med; 1981 Jun; 153(6):1604-14. PubMed ID: 6166719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic peptide corresponding to the phosphorylcholine (PC)-binding region of human C-reactive protein possesses the TEPC-15 myeloma PC-idiotype.
    Swanson SJ; Lin BF; Mullenix MC; Mortensen RF
    J Immunol; 1991 Mar; 146(5):1596-601. PubMed ID: 1704398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-specific anti-phosphocholine antibodies: binding site studies.
    Claflin JL; Hudak S; Maddalena A; Bender T
    J Immunol; 1985 Apr; 134(4):2536-43. PubMed ID: 2579145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding and immunological properties of a synthetic peptide corresponding to the phosphorylcholine-binding region of C-reactive protein.
    Swanson SJ; Mortensen RF
    Mol Immunol; 1990 Jul; 27(7):679-87. PubMed ID: 2395439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of phosphorylcholine by non-immunoglobulin molecules on mouse B cells.
    Bach MA; Kohler H; Levitt D
    J Immunol; 1983 Jul; 131(1):365-9. PubMed ID: 6863921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of low density lipoprotein (LDL) to C-reactive protein (CRP): a possible binding through apolipoprotein B in LDL at phosphorylcholine-binding site of CRP.
    Nunomura W; Hatakeyama M
    Hokkaido Igaku Zasshi; 1990 Sep; 65(5):474-80. PubMed ID: 2227796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of the binding of human C-reactive protein (CRP) to laminin.
    Swanson SJ; McPeek MM; Mortensen RF
    J Cell Biochem; 1989 May; 40(1):121-32. PubMed ID: 2745572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
    Jiang HX; Siegel JN; Gewurz H
    J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies.
    Ying SC; Gewurz H; Kinoshita CM; Potempa LA; Siegel JN
    J Immunol; 1989 Jul; 143(1):221-8. PubMed ID: 2471736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
    Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
    J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of antibody responses to phosphocholine by C-reactive protein.
    Nakayama S; Du Clos TW; Gewurz H; Mold C
    J Immunol; 1984 Mar; 132(3):1336-40. PubMed ID: 6363539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of phosphorylcholine binding to antibodies using synthetic peptides.
    Lai EH; Kabat EA; Meienhofer J; Heimer EP; Olson AJ; Lerner R
    Nature; 1987 Jan 8-14; 325(7000):168-71. PubMed ID: 3808074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic memory to phosphocholine. IV. Hybridomas representative of Group I (T15-like) and Group II (non-T15-like) antibodies utilize distinct VH genes.
    Chang SP; Perlmutter RM; Brown M; Heusser CH; Hood L; Rittenberg MB
    J Immunol; 1984 Mar; 132(3):1550-5. PubMed ID: 6420466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate-binding properties of human neo-CRP and its relationship to phosphorylcholine-binding site.
    Lee RT; Lee YC
    Glycobiology; 2003 Jan; 13(1):11-21. PubMed ID: 12634320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The physiological structure of human C-reactive protein and its complex with phosphocholine.
    Thompson D; Pepys MB; Wood SP
    Structure; 1999 Feb; 7(2):169-77. PubMed ID: 10368284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.